Pharmaceutical company Lupin has announced a non-exclusive patent licence agreement with Takeda Pharmaceutical for the ...

In a report released today, Joseph Stringer from Needham reiterated a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report), ...

The US regulator has cleared two therapies based on Phathom's acid blocker vonoprazan in combination with antibiotics for Helicobacter pylori infections , which are associated with peptic ulcer ...

Net revenues of $16.4 million reported for the third quarter 2024 compared to $7.3 million in the second quarter 2024, over 120% sequential ...

A third option consists of a new, highly potent drug called vonoprazan, combined with the antibiotic amoxicillin, that blocks ...

New Delhi: Hetero Labs has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Our Bureau, New Delhi Wednesday, November 6, 2024, 13:45 Hrs [IST] Dr Reddy's Laboratories has reported a decline of 9.36 pe ...

Hyderabad-based Dr Reddy's Laboratories (DRL) posted a 9.5 per cent year-on-year (Y-o-Y) decline in its consolidated profit ...

Please visit voqueznapro.com to learn more about VOQUEZNA. VOQUEZNA® (vonoprazan) tablets contain vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel ...

Other medications can affect the removal of vonoprazan from your body, which may affect how vonoprazan works. Examples include rifamycins (such as rifabutin), among others. Do not share this ...

Background and Aim: Common endoscopic findings in stomachs with Helicobacter pylori infections include antral nodularity, thickened gastric folds, and visible submucosal vessels. These findings ...